Recommendations for detection, validation, and evaluation of RNA editing events in cardiovascular and neurological/neurodegenerative diseases
© 2023 The Author(s)..
RNA editing, a common and potentially highly functional form of RNA modification, encompasses two different RNA modifications, namely adenosine to inosine (A-to-I) and cytidine to uridine (C-to-U) editing. As inosines are interpreted as guanosines by the cellular machinery, both A-to-I and C-to-U editing change the nucleotide sequence of the RNA. Editing events in coding sequences have the potential to change the amino acid sequence of proteins, whereas editing events in noncoding RNAs can, for example, affect microRNA target binding. With advancing RNA sequencing technology, more RNA editing events are being discovered, studied, and reported. However, RNA editing events are still often overlooked or discarded as sequence read quality defects. With this position paper, we aim to provide guidelines and recommendations for the detection, validation, and follow-up experiments to study RNA editing, taking examples from the fields of cardiovascular and brain disease. We discuss all steps, from sample collection, storage, and preparation, to different strategies for RNA sequencing and editing-sensitive data analysis strategies, to validation and follow-up experiments, as well as potential pitfalls and gaps in the available technologies. This paper may be used as an experimental guideline for RNA editing studies in any disease context.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
|---|---|
| Enthalten in: |
Molecular therapy. Nucleic acids - 35(2024), 1 vom: 12. Jan., Seite 102085 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Karagianni, Korina [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
A-to-I editing |
|---|
| Anmerkungen: |
Date Revised 10.01.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.omtn.2023.102085 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366832131 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366832131 | ||
| 003 | DE-627 | ||
| 005 | 20240114233550.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240114s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.omtn.2023.102085 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1255.xml |
| 035 | |a (DE-627)NLM366832131 | ||
| 035 | |a (NLM)38192612 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Karagianni, Korina |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Recommendations for detection, validation, and evaluation of RNA editing events in cardiovascular and neurological/neurodegenerative diseases |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 10.01.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2023 The Author(s). | ||
| 520 | |a RNA editing, a common and potentially highly functional form of RNA modification, encompasses two different RNA modifications, namely adenosine to inosine (A-to-I) and cytidine to uridine (C-to-U) editing. As inosines are interpreted as guanosines by the cellular machinery, both A-to-I and C-to-U editing change the nucleotide sequence of the RNA. Editing events in coding sequences have the potential to change the amino acid sequence of proteins, whereas editing events in noncoding RNAs can, for example, affect microRNA target binding. With advancing RNA sequencing technology, more RNA editing events are being discovered, studied, and reported. However, RNA editing events are still often overlooked or discarded as sequence read quality defects. With this position paper, we aim to provide guidelines and recommendations for the detection, validation, and follow-up experiments to study RNA editing, taking examples from the fields of cardiovascular and brain disease. We discuss all steps, from sample collection, storage, and preparation, to different strategies for RNA sequencing and editing-sensitive data analysis strategies, to validation and follow-up experiments, as well as potential pitfalls and gaps in the available technologies. This paper may be used as an experimental guideline for RNA editing studies in any disease context | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a A-to-I editing | |
| 650 | 4 | |a C-to-U editing | |
| 650 | 4 | |a MT: RNA/DNA editing | |
| 650 | 4 | |a RNA editing | |
| 650 | 4 | |a cardiovascular disease | |
| 650 | 4 | |a methodology | |
| 650 | 4 | |a neurodegenerative disease | |
| 650 | 4 | |a neurovascular disease | |
| 700 | 1 | |a Bibi, Alessia |e verfasserin |4 aut | |
| 700 | 1 | |a Madé, Alisia |e verfasserin |4 aut | |
| 700 | 1 | |a Acharya, Shubhra |e verfasserin |4 aut | |
| 700 | 1 | |a Parkkonen, Mikko |e verfasserin |4 aut | |
| 700 | 1 | |a Barbalata, Teodora |e verfasserin |4 aut | |
| 700 | 1 | |a Srivastava, Prashant K |e verfasserin |4 aut | |
| 700 | 1 | |a de Gonzalo-Calvo, David |e verfasserin |4 aut | |
| 700 | 1 | |a Emanueli, Constanza |e verfasserin |4 aut | |
| 700 | 1 | |a Martelli, Fabio |e verfasserin |4 aut | |
| 700 | 1 | |a Devaux, Yvan |e verfasserin |4 aut | |
| 700 | 1 | |a Dafou, Dimitra |e verfasserin |4 aut | |
| 700 | 1 | |a Nossent, A Yaël |e verfasserin |4 aut | |
| 700 | 0 | |a EU-CardioRNA COST Action CA17129 |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Molecular therapy. Nucleic acids |d 2012 |g 35(2024), 1 vom: 12. Jan., Seite 102085 |w (DE-627)NLM222953810 |x 2162-2531 |7 nnns |
| 773 | 1 | 8 | |g volume:35 |g year:2024 |g number:1 |g day:12 |g month:01 |g pages:102085 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.omtn.2023.102085 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 35 |j 2024 |e 1 |b 12 |c 01 |h 102085 | ||